Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones
- Exp. Mol. Med., Jul 04 2025, | https://doi.org/10.1038/s12276-025-01493-2